Investor Relations

On these pages you will find the articles and by-laws of the company as well as current information regarding Sangui share price.

In order to facilitate information processes for our shareholders the frequently asked questions section ("FAQ") will not only contain basic information but will also be updated on a regular basis.

On the page Share History you will find an overview of changes in Stockholders' Equity since the inception of the company in 1996.

Please note, that Sangui continues to be a high risk investment. Investors should be aware of the risk sections included in our recent SEC filings. Comprehensive risk information is contained in the risk memorandum avalailable for download here.

Holding a General Meeting of our Shareholders depends on completing our filings with the SEC. The financial statements of our 2006 and 2007 fiscal years including the quarterly reports are currently under preparation and subject to a review or an audit carried out by an independent auditor. As soon as the company is current with its filing our shareholders will be invited to a General Meeting.

No. of Sangui shares issued and outstanding: 50,000,000

No. of Sangui shares authorized: 50,000,000 common stock, 5,000,000 preferred stock

Cusip No.: 80105B101 ISIN: US80105B1017

Traded: www.pinksheets.com (symbol: SGBI)

WKN: 906757

Traded: OTC market in Hamburg (Symbol: SBH)